- About Us
- Services & Solutions
- Technologies
- Discovery
- Reagent Materials Generation
- Monoclonal Antibody Discovery
- Bispecific & Multispecific Antibody Generation
- Lead Optimization
- In Vitro Lead Characterization
- In Vivo Lead Characterization
- Other Molecular Modalities
- IND Filing Support
- Protein Sciences
- Antibody Production
- Protein Production
- Protein Characterization
- Protein Sciences
- Mammalian
- Microbial
- mRNA
- Viral Vaccines
- WuXi XDC – Bioconjugation
- Testing
- Sustainability
- Careers
- Investors
- News & Resources
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- SustainabilityAbout Us
- CareersAbout Us
- InvestorsAbout Us
- News & ResourcesAbout Us
Services & Solutions
Information Downloads
Poster modified on 16/02/2024
Bioconjugation Discovery Services
From Target to Lead - Comprehensive Discovery Services for ADCs/Bioconjugates
|
WuXi XDC is a Contract Research, Development and Manufacturing Organization (CRDMO) dedicated to providing end-to-end discovery, development, and manufacturing services for antibody drug conjugates (ADCs) and other bioconjugates. Our one-stop comprehensive technology platform greatly simplifies bioconjugate drug or diagnostic and imaging reagent development by providing lead screening and selection, preclinical activities, holistic and integrated CMC development, and the entire production supply chain, with one company and in one centralized region. |
Discuss This Service Overview
To discuss the information in this service overview, please complete the form on the following page to connect with our experts.